MicroRNAs (miRNAs) are key regulatory elements encoded by the genome. A single miRNA can downregulate the expression of multiple genes involved in diverse functions. Because cancer is a disease with multiple gene aberrations, developing novel approaches to identify and modulate miRNA pathways may result in a breakthrough for cancer treatment. With a special focus on glioblastoma (GBM), this review provides an up-to-date summary of miRNA biogenesis, the role of miRNA in cancer resistance, and essential tools for modulating miRNA expression, as well as of clinically promising RNAi delivery systems and how they can be adapted for therapy.
A lire aussi
Recruitment of 2 Research Assistants on one-year fixed-term contracts
02 April 2025
par Laetitia Legoupil
2025, April 4 : seminar of Prof. Marek Tchorzewski
28 March 2025
par Laetitia Legoupil
Combination of nanomedicine and biophysics methods to characterize mRNA liposomes
18 March 2025
par Laetitia Legoupil